Fosl1 is a transcriptional effector of BRAF V600E-driven intestinal tumorigenesis.

Saved in:
Bibliographic Details
Title: Fosl1 is a transcriptional effector of BRAF V600E-driven intestinal tumorigenesis.
Authors: Alam Z; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Nightingale R; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Lesmana A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Liu C; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; Mater Pathology, Mater Hospital Brisbane, South Brisbane, QLD, Australia., Jenkins LJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Richardson MF; School of Life and Environment Sciences, Deakin University, Geelong, VIC, Australia., Croft L; School of Life and Environment Sciences, Deakin University, Geelong, VIC, Australia., Luk IY; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Reehorst CM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Chionh F; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Vukelic N; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Basheer F; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia., Tulchinsky E; Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan., Badshah J; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Dumenil T; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Bakiri L; Laboratory of Gene and Disease, Department of Medicine, Medical University of Vienna (MUW), Vienna, Austria., Wagner EF; Laboratory of Gene and Disease, Department of Medicine, Medical University of Vienna (MUW), Vienna, Austria.; Laboratory of Gene and Disease, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria., Tebbutt NC; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia., Whitehall V; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Mariadason JM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia., Dhillon AS; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia.
Source: IScience [iScience] 2025 Oct 28; Vol. 28 (11), pp. 113875. Date of Electronic Publication: 2025 Oct 28 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2025.113875